Marker Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 617,614, but the productivity of Marker Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 104 other companies have achieved higher revenue per employee. While Marker Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1086. Marker Therapeutics Inc has 5 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRKR Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	-	115.32 %	-51 %	-35.99 %	-26.35 %
Sales per Employee (TTM) $	617,614	789,851	709,334	938,998	1,077,614
MRKR's Total Ranking	# 1086	# 0	# 2811	# 2427	# 2725
Seq. Revenue Change	-	-31.88 %	-10.5 %	43.17 %	146.68 %

MRKR Company Profile >> Back to MRKR Efficiency Comparisons >> Compare MRKR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 73
Healthcare Sector	# 105
Overall Market	# 1086

Revenue per Employee Statistics
High	Average	Low
$ 2,556,712	$ 1,329,122	$ 664,171
(Mar 31 2023)		(Mar 31 2024)

Financial Statements
Marker Therapeutics Inc 's Revenue MRQ	$ 0 Millions	Visit MRKR's Income Statement
Marker Therapeutics Inc 's Revenues TTM	$ 3 Millions	Visit MRKR's aggregate revenue growth
What are MRKR's Sales?		Visit MRKR's Sales by Segment

Other Ratios
Marker Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MRKR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MRKR's Competitors
Revenue per Employee for MRKR's Suppliers
Revenue per Employee for MRKR's Customers

You may also want to know
MRKR's Sales Growth Rates	MRKR's Pe Price to earnings ratio	MRKR's Receivables Turnover Ratio	MRKR's Stock Quote
MRKR's Net Income Growth Rates	MRKR's Ps Price to Sales ratio	MRKR's Sales per Employee	MRKR's Asset Turnover Ratio
MRKR's Net Margin	MRKR's Pb Price to Book ratio	MRKR's Financial Strength Ratios	MRKR's Dividend Payout Ratio

Date modified: 2026-09-12T06:13:23+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ptc Therapeutics inc	1,017,915.24	$ 1,008.754 Million	991
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Regeneron Pharmaceuticals Inc	1,008,092.15	$ 15,534.700 Million	15,410
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Evolus Inc	949,440.12	$ 317.113 Million	334
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Ardelyx inc	922,073.62	$ 450.894 Million	489
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Carlisle Companies Incorporated	863,898.31	$ 5,097.000 Million	5,900
Verastem Inc	858,098.04	$ 87.526 Million	102
Emergent Biosolutions Inc	855,777.78	$ 770.200 Million	900
Bridgebio Pharma Inc	849,903.46	$ 713.069 Million	839
Pfizer Inc	849,280.00	$ 63,696.000 Million	75,000
Syndax Pharmaceuticals Inc	845,651.01	$ 252.004 Million	298
Xilio Therapeutics Inc	843,315.79	$ 64.092 Million	76
Axsome Therapeutics Inc	839,534.05	$ 776.569 Million	925
Ionis Pharmaceuticals Inc	834,107.70	$ 1,169.419 Million	1,402
Vir Biotechnology Inc	826,231.61	$ 303.227 Million	367
Immunocore Holdings Plc	822,089.69	$ 430.775 Million	524

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.